Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1988 Nov;60(5):397–403. doi: 10.1136/hrt.60.5.397

High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

M Barbir 1, D Wile 1, I Trayner 1, V R Aber 1, G R Thompson 1
PMCID: PMC1216597  PMID: 3203033

Abstract

Serum lipids and apolipoproteins A-I and B were measured in 174 men aged less than 60 with angiographically confirmed coronary artery disease and in 572 healthy control men. Two thirds of the patients had raised age-corrected values of fasting serum cholesterol and/or triglyceride and/or a low high density lipoprotein (HDL) cholesterol compared with the controls. Eighteen (30%) of the 61 normolipidaemic patients had a concentration of serum apolipoprotein A-I below the 5th percentile of 233 controls. In normolipidaemic patients on beta blockers the relative prevalence of serum low density lipoprotein (LDL)-apolipoprotein B values above the 95th percentile of 339 controls was significantly increased. Discriminant function analysis showed that a raised concentration of serum triglyceride was the best discriminant between patients and controls, with raised LDL-apolipoprotein B and reduced apolipoprotein A-I coming second only to triglyceride in analyses where each was separately compared with all the lipid variables. These associations were highly significant and were independent of other influences, including beta blockade. These findings re-emphasise the importance of hypertriglyceridaemia as a risk factor and confirm that apolipoprotein abnormalities occur frequently in coronary disease, even in normolipidaemic patients.

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg K., Börresen A. L., Dahlen G. Effect of smoking on serum levels of HDL apoproteins. Atherosclerosis. 1979 Nov;34(3):339–343. doi: 10.1016/s0021-9150(79)80011-8. [DOI] [PubMed] [Google Scholar]
  2. Brunzell J. D., Sniderman A. D., Albers J. J., Kwiterovich P. O., Jr Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 1984 Mar-Apr;4(2):79–83. doi: 10.1161/01.atv.4.2.79. [DOI] [PubMed] [Google Scholar]
  3. Cambien F., Warnet J. M., Jacqueson A., Ducimetiere P., Richard J. L., Claude J. R. Relation of parental history of early myocardial infarction to the level of apoprotein B in men. Circulation. 1987 Aug;76(2):266–271. doi: 10.1161/01.cir.76.2.266. [DOI] [PubMed] [Google Scholar]
  4. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  5. Castelli W. P. The triglyceride issue: a view from Framingham. Am Heart J. 1986 Aug;112(2):432–437. doi: 10.1016/0002-8703(86)90296-6. [DOI] [PubMed] [Google Scholar]
  6. De Backer G., Hulstaert F., De Munck K., Rosseneu M., Van Parijs L., Dramaix M. Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction. Am Heart J. 1986 Sep;112(3):478–484. doi: 10.1016/0002-8703(86)90510-7. [DOI] [PubMed] [Google Scholar]
  7. Durrington P. N., Hunt L., Ishola M., Kane J., Stephens W. P. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J. 1986 Sep;56(3):206–212. doi: 10.1136/hrt.56.3.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freedman D. S., Srinivasan S. R., Shear C. L., Franklin F. A., Webber L. S., Berenson G. S. The relation of apolipoproteins A-I and B in children to parental myocardial infarction. N Engl J Med. 1986 Sep 18;315(12):721–726. doi: 10.1056/NEJM198609183151202. [DOI] [PubMed] [Google Scholar]
  9. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  10. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1533–1543. doi: 10.1172/JCI107331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamsten A., Walldius G., Szamosi A., Dahlen G., de Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation. 1986 Jun;73(6):1097–1110. doi: 10.1161/01.cir.73.6.1097. [DOI] [PubMed] [Google Scholar]
  12. Havekes L., Hemmink J., de Wit E. Low-density-lipoprotein apoprotein B in plasma as measured by radial immunodiffusion and rocket immunoelectrophoresis. Clin Chem. 1981 Nov;27(11):1829–1833. [PubMed] [Google Scholar]
  13. Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
  14. Ishikawa T., Fidge N., Thelle D. S., Førde O. H., Miller N. E. The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease. Eur J Clin Invest. 1978 Jun;8(3):179–182. doi: 10.1111/j.1365-2362.1978.tb00832.x. [DOI] [PubMed] [Google Scholar]
  15. Kottke B. A., Zinsmeister A. R., Holmes D. R., Jr, Kneller R. W., Hallaway B. J., Mao S. J. Apolipoproteins and coronary artery disease. Mayo Clin Proc. 1986 May;61(5):313–320. doi: 10.1016/s0025-6196(12)61947-8. [DOI] [PubMed] [Google Scholar]
  16. Kukita H., Hamada M., Hiwada K., Kokubu T. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease. Atherosclerosis. 1985 May;55(2):143–149. doi: 10.1016/0021-9150(85)90093-0. [DOI] [PubMed] [Google Scholar]
  17. Kukita H., Hiwada K., Kokubu T. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. Atherosclerosis. 1984 May-Jun;51(2-3):261–267. doi: 10.1016/0021-9150(84)90173-4. [DOI] [PubMed] [Google Scholar]
  18. Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Martin M. J., Hulley S. B., Browner W. S., Kuller L. H., Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986 Oct 25;2(8513):933–936. doi: 10.1016/s0140-6736(86)90597-0. [DOI] [PubMed] [Google Scholar]
  20. Nikkilä E. A., Kuusi T., Myllynen P. High density lipoprotein and apolipoprotein A-i during physical inactivity. Demonstration at low levels in patients with spine fracture. Atherosclerosis. 1980 Nov;37(3):457–462. doi: 10.1016/0021-9150(80)90151-3. [DOI] [PubMed] [Google Scholar]
  21. Ordovas J. M., Schaefer E. J., Salem D., Ward R. H., Glueck C. J., Vergani C., Wilson P. W., Karathanasis S. K. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med. 1986 Mar 13;314(11):671–677. doi: 10.1056/NEJM198603133141102. [DOI] [PubMed] [Google Scholar]
  22. Pocock S. J., Shaper A. G., Phillips A. N., Walker M., Whitehead T. P. High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):515–519. doi: 10.1136/bmj.292.6519.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reardon M. F., Nestel P. J., Craig I. H., Harper R. W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985 May;71(5):881–888. doi: 10.1161/01.cir.71.5.881. [DOI] [PubMed] [Google Scholar]
  24. Rifai N., King M. E. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. Clin Chem. 1986 Jun;32(6):957–961. [PubMed] [Google Scholar]
  25. Schmidt S. B., Wasserman A. G., Muesing R. A., Schlesselman S. E., Larosa J. C., Ross A. M. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1459–1462. doi: 10.1016/0002-9149(85)90953-1. [DOI] [PubMed] [Google Scholar]
  26. Sedlis S. P., Schechtman K. B., Ludbrook P. A., Sobel B. E., Schonfeld G. Plasma apoproteins and the severity of coronary artery disease. Circulation. 1986 May;73(5):978–986. doi: 10.1161/01.cir.73.5.978. [DOI] [PubMed] [Google Scholar]
  27. Shaper A. G., Pocock S. J. British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) 1985 Aug 17;291(6493):480–481. doi: 10.1136/bmj.291.6493.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shaper A. G., Pocock S. J., Walker M., Phillips A. N., Whitehead T. P., Macfarlane P. W. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health. 1985 Sep;39(3):197–209. doi: 10.1136/jech.39.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sniderman A. D., Wolfson C., Teng B., Franklin F. A., Bachorik P. S., Kwiterovich P. O., Jr Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982 Dec;97(6):833–839. doi: 10.7326/0003-4819-97-6-833. [DOI] [PubMed] [Google Scholar]
  30. Sniderman A., Teng B., Genest J., Cianflone K., Wacholder S., Kwiterovich P., Jr Familial aggregation and early expression of hyperapobetalipoproteinemia. Am J Cardiol. 1985 Feb 1;55(4):291–295. doi: 10.1016/0002-9149(85)90363-7. [DOI] [PubMed] [Google Scholar]
  31. Sniderman A., Teng B., Jerry M. Determination of B protein of low density lipoprotein directly in plasma. J Lipid Res. 1975 Nov;16(6):465–467. [PubMed] [Google Scholar]
  32. Teng B., Sniderman A. D., Soutar A. K., Thompson G. R. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest. 1986 Mar;77(3):663–672. doi: 10.1172/JCI112360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thompson G. Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk. Br Heart J. 1984 Jun;51(6):585–588. doi: 10.1136/hrt.51.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Warnick G. R., Albers J. J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978 Jan;19(1):65–76. [PubMed] [Google Scholar]
  35. Warnick G. R., Benderson J., Albers J. J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 Jun;28(6):1379–1388. [PubMed] [Google Scholar]
  36. Warnick G. R., Nguyen T., Albers A. A. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985 Feb;31(2):217–222. [PubMed] [Google Scholar]
  37. Yaari S., Goldbourt, Even-Zohar S., Neufeld H. N. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men. Lancet. 1981 May 9;1(8228):1011–1015. doi: 10.1016/s0140-6736(81)92184-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES